Chemomab Therapeutics Ltd. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Chemomab Therapeutics Ltd. (CMMB) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of $6.08 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2019-04-24
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2018-12-31 | $6.08M 20-F · filed 2019-04-24 |
| 2017-12-31 | -$3.31M 20-F · filed 2019-04-24 |
| 2016-12-31 | $2.41M 20-F · filed 2019-04-24 |